Entity family
Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.
Showing 421–480 of 9,496, ordered by supporting articles. Choose a drug to see its evidence.
… full analysis set, 113 received GUS 100mg SC Q8W, 115 received GUS 200mg SC Q4W, and 58 received PBO. 91.3% completed the 24 weeks…
…Introduction Upadacitinib (UPA) is an oral, reversible Janus tyrosine kinase inhibitor (J…
… restricted with only 50.7% of services reporting access.In CD, vedolizumab was accessible in 64/71 services (90.1%), including 31 (43.7%) …
… during treatment with PD-1 inhibitors. Eight patients received pembrolizumab (six as monotherapy and two in combination with carboplatin plu…
…nts were included (437 pre-shortage and 416 post-shortage). The Pabrinex shortage led to guideline changes in all included trusts. There…
…immune-related adverse events (irAEs). Janus kinase inhibitors (JAKi) are a promising steroid-sparing agent for treating corticoster…
…) block. In the current study, we planned to compare perineural dexamethasone (PN-Dex) and intravenous Dex in the PEC block in patients under…
…n and improvement were 48.5% and 38.8%, respectively. Long-term natalizumab treatment significantly decreased ARR compared with short-term …
…eated with geroprotector drugs including metformin, statins and fisetin, every 2 days for 7 days. Transcription factors (including MYC)…
…h PFA catheters in total of 40 patients with persistent AF (12% pentaspline, 28% FLCC, and 13% VLCC). Overall, 30-day major cardiac events …
…rdiovascular events (MACE). Anti-inflammatory therapies such as colchicine and canakinumab have reduced MACE in chronic coronary syndromes…
…titial fibrosis in the males than in the females in response to SuHx. While RCA intima-media thickness did not change in response to…